exosomes/extracellular vesicles
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.
Biological Dynamics Partners With Pancreatic Cancer Consortium On Early Detection Study
The firm aims to recruit at least 1,000, and up to 5,000, individuals at an elevated risk for pancreatic cancer, comparing its test to standard-of-care surveillance.
Mercy BioAnalytics Raises $41M in Series A Financing
The proceeds will help develop and commercialize its extracellular vesicle-based Mercy Halo platform for lung, ovarian, and other cancer screening tests.
Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection Test
The collaboration will involve testing 520 samples from pancreatic cancer patients and healthy individuals using the exosome-isolating ExoVita Pancreas assay.
Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test
Research companies Curta and Qure Healthcare will be conducting an economic modeling and physician behavior study, respectively.